Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action. [electronic resource]
- Journal of cardiovascular pharmacology and therapeutics 09 2016
- 478-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1940-4034
10.1177/1074248415626300 doi
Aldehyde Oxidoreductases--antagonists & inhibitors Animals Dose-Response Relationship, Drug Endothelial Cells--drug effects Enzyme Inhibitors--pharmacology Macrophages--drug effects Male Mice Mice, Inbred C57BL Mice, Knockout Myocytes, Cardiac--drug effects Nebivolol--pharmacology Nitric Oxide--metabolism Nitric Oxide Synthase Type III--deficiency Oxidation-Reduction Protein Processing, Post-Translational--drug effects RAW 264.7 Cells Rats, Sprague-Dawley S-Nitrosoglutathione--metabolism Vasodilation--drug effects Vasodilator Agents--pharmacology